Drug Profile
Immunoglobulin G - China Biologic Products
Alternative Names: Human immunoglobulin; Human immunoglobulin 10%; Human immunoglobulin 5%; Immunoglobulin intravenous 10% - China Biologic Products; Immunoglobulin intravenous 5% - China Biologic Products; Intravenous immunoglobulin - China Biologic Products; IVIG - China Biologic ProductsLatest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator China Biologic Products
- Class Immunoglobulin isotypes
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Immunodeficiency disorders
Most Recent Events
- 25 Feb 2016 China Biologic Products receives approval for clinical trial by the CFDA (China Biologic Products, Form 10-K, February 2016)
- 01 Jan 2014 Launched prior to 2014 for Immunodeficiency disorders in China (IV; 5% and 10%)